Cargando…

122: Assessment of the Usage of Hypofractionation for Prostate Cancer in an LMIC Before and After the COVID-19 Pandemic

Detalles Bibliográficos
Autores principales: Asso, Rie, Patrocinio, Horacio, Ramia, Paul, Castilho, Marcos, Rosa, Arthur, Silva, Joao Luis, Cury, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ireland Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500566/
http://dx.doi.org/10.1016/S0167-8140(22)04401-2
_version_ 1784795251603406848
author Asso, Rie
Patrocinio, Horacio
Ramia, Paul
Castilho, Marcos
Rosa, Arthur
Silva, Joao Luis
Cury, Fabio
author_facet Asso, Rie
Patrocinio, Horacio
Ramia, Paul
Castilho, Marcos
Rosa, Arthur
Silva, Joao Luis
Cury, Fabio
author_sort Asso, Rie
collection PubMed
description
format Online
Article
Text
id pubmed-9500566
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ireland Ltd.
record_format MEDLINE/PubMed
spelling pubmed-95005662022-09-23 122: Assessment of the Usage of Hypofractionation for Prostate Cancer in an LMIC Before and After the COVID-19 Pandemic Asso, Rie Patrocinio, Horacio Ramia, Paul Castilho, Marcos Rosa, Arthur Silva, Joao Luis Cury, Fabio Radiother Oncol Article Elsevier Ireland Ltd. 2022-09 2022-09-23 /pmc/articles/PMC9500566/ http://dx.doi.org/10.1016/S0167-8140(22)04401-2 Text en Copyright © 2022 Elsevier Ireland Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Asso, Rie
Patrocinio, Horacio
Ramia, Paul
Castilho, Marcos
Rosa, Arthur
Silva, Joao Luis
Cury, Fabio
122: Assessment of the Usage of Hypofractionation for Prostate Cancer in an LMIC Before and After the COVID-19 Pandemic
title 122: Assessment of the Usage of Hypofractionation for Prostate Cancer in an LMIC Before and After the COVID-19 Pandemic
title_full 122: Assessment of the Usage of Hypofractionation for Prostate Cancer in an LMIC Before and After the COVID-19 Pandemic
title_fullStr 122: Assessment of the Usage of Hypofractionation for Prostate Cancer in an LMIC Before and After the COVID-19 Pandemic
title_full_unstemmed 122: Assessment of the Usage of Hypofractionation for Prostate Cancer in an LMIC Before and After the COVID-19 Pandemic
title_short 122: Assessment of the Usage of Hypofractionation for Prostate Cancer in an LMIC Before and After the COVID-19 Pandemic
title_sort 122: assessment of the usage of hypofractionation for prostate cancer in an lmic before and after the covid-19 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500566/
http://dx.doi.org/10.1016/S0167-8140(22)04401-2
work_keys_str_mv AT assorie 122assessmentoftheusageofhypofractionationforprostatecancerinanlmicbeforeandafterthecovid19pandemic
AT patrociniohoracio 122assessmentoftheusageofhypofractionationforprostatecancerinanlmicbeforeandafterthecovid19pandemic
AT ramiapaul 122assessmentoftheusageofhypofractionationforprostatecancerinanlmicbeforeandafterthecovid19pandemic
AT castilhomarcos 122assessmentoftheusageofhypofractionationforprostatecancerinanlmicbeforeandafterthecovid19pandemic
AT rosaarthur 122assessmentoftheusageofhypofractionationforprostatecancerinanlmicbeforeandafterthecovid19pandemic
AT silvajoaoluis 122assessmentoftheusageofhypofractionationforprostatecancerinanlmicbeforeandafterthecovid19pandemic
AT curyfabio 122assessmentoftheusageofhypofractionationforprostatecancerinanlmicbeforeandafterthecovid19pandemic